1. Arbutin suppresses osteosarcoma progression via miR‐338‐3p /MTHFD1L and inactivation of the AKT/mTOR pathway
- Author
-
Cheng-Qun Wang, Yuan-Min Zhang, Lei Wang, Xiu-Mei Wang, and Bing-Liang Li
- Subjects
0301 basic medicine ,Cell Survival ,proliferation ,AKT/mTOR ,Bone Neoplasms ,General Biochemistry, Genetics and Molecular Biology ,Formate-Tetrahydrofolate Ligase ,MTHFD1L ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cyclin D1 ,Aminohydrolases ,Cell Movement ,Multienzyme Complexes ,Cell Line, Tumor ,Humans ,Viability assay ,Protein kinase B ,Research Articles ,miR‐338‐3p ,PI3K/AKT/mTOR pathway ,Methylenetetrahydrofolate Dehydrogenase (NADP) ,Osteosarcoma ,Kinase ,Cell growth ,TOR Serine-Threonine Kinases ,Arbutin ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,030104 developmental biology ,chemistry ,Cell culture ,Gene Knockdown Techniques ,030220 oncology & carcinogenesis ,Cancer research ,Proto-Oncogene Proteins c-akt ,Research Article ,Signal Transduction - Abstract
Arbutin, a natural polyphenol, inhibits OS cell viability, invasion and migration by down‐regulating MTHFD1L expression. miR‐338‐3p directly targets MTHFD1L. This regulatory action is associated with the inactivation of the AKT/mTOR signaling pathway., Arbutin, a glycoside extracted from the plant Arctostaphylos uva‐ursi, has been previously reported to possess antioxidant, anti‐inflammatory and anticancer effects. Here, we investigated whether arbutin affects the proliferation of the cells of the osteosarcoma (OS) cell lines MG‐63 and SW1353. Arbutin suppressed OS cell viability in a dose‐ and time‐dependent manner, as shown by Cell Counting Kit‐8 assay. Furthermore, arbutin exposure decreased the protein levels of MTHFD1L, CCND1 and phosphorylated‐protein kinase B (AKT)/phosphorylated‐mammalian target of rapamycin (mTOR). Potential upstream miRNAs of MTHFD1L were predicted using TargetScan, PICTAR5, miRanda and miRWalk. We performed luciferase activity assays to show that miR‐338‐3p directly targets and negatively regulates the expression of MTHFD1L. Knockdown of miR‐338‐3p promoted cell invasion, migration and proliferation in arbutin‐treated OS cells via MTHFD1L. In summary, our data suggest that arbutin inhibits OS cell proliferation, migration and invasion via miR‐338‐3p/MTHFD1L and by inactivating the AKT/mTOR pathway.
- Published
- 2020